AbCellera Biologics Inc.
ABCL · NASDAQ
Bulios Fair Price
$11.1
12.1% downside
Trenutna cena
$12.63
Po podatkih Bulios Fair Price je delnica ABCL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
AbCellera Biologics Inc. (ABCL) is a biotechnology company specializing in the development of monoclonal antibodies and other biological therapeutics for the treatment of various diseases, including infectious diseases and cancer. The company utilizes advanced technologies such as artificial intelligence and wide-scale antibody scanning to identify and develop potentially effective therapies. AbCellera collaborates with pharmaceutical companies on drug development and therapeutic approaches. With its innovations in the field of biological therapeutics and partnerships with the pharmaceutical industry, investing in AbCellera Biologics Inc. (ABCL) shares may present an interesting investment opportunity for investors interested in the biotechnology and medical sectors.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Carl Hansen
Employees
562
Headquarters
Vancouver
Prihajajoči dogodki
Earnings
Upcoming earnings report